The histone deacetylase inhibitor trichostatin a derepresses the telomerase reverse transcriptase (hTERT) gene in human cells

被引:106
作者
Hou, M
Wang, XB
Popov, N
Zhang, AJ
Zhao, XY
Zhou, R
Zetterberg, A
Björkholm, M
Henriksson, M
Gruber, A
Xu, DW
机构
[1] Karolinska Hosp & Inst, Dept Med, Div Hematol, Stockholm, Sweden
[2] Karolinska Hosp & Inst, Ctr Mol Med, Immunol Res Lab, Stockholm, Sweden
[3] Karolinska Hosp & Inst, Canc Ctr Karolinska, Dept Oncol & Pathol, Stockholm, Sweden
[4] Karolinska Hosp & Inst, Ctr Microbiol & Tumor Biol, Stockholm, Sweden
关键词
D O I
10.1006/excr.2001.5462
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Activation of telomerase, essential for cellular immortalization and transformation, requires the induction of its catalytic component, telomerase reverse transcriptase (hTERT). However, biochemical and genetic mechanisms for the control of hTERT expression remain undefined. In the present study, we demonstrate that the histone deacetylase (HDAC) inhibitor trichostatin A (TSA) induces hyperacetylation of histones at the hTERT proximal promoter, directly transactivates the hTERT gene in normal human telomerase-negative cells, and upregulates hTERT expression in telomerase-positive tumor cells. Overexpression. of HDAC1 leads to repression of the hTERT promoter activity. TSA-mediated activation of the hTERT promoter is abolished by the mutation of Sp1 sites at the proximal promoter, suggesting that the effect of TSA is regulated through Sp1 motifs. We also show a physical interaction of Sp1 with HDAC1 and the presence of HDAC1 at the hTERT promoter region. Moreover, hyperacetylation of histones at the hTERT promoter is associated with the natural up-regulation of hTERT expression that occurs in activated T lymphocytes. Taken together, histone acetylation/deacetylation may be a common underlying feature to hTERT transactivation/repression in human normal and malignant cells. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:25 / 34
页数:10
相关论文
共 39 条
  • [31] Takakura M, 1999, CANCER RES, V59, P551
  • [32] Telomerase activation by histone deacetylase inhibitor in normal cells
    Takakura, M
    Kyo, S
    Sowa, Y
    Wang, Z
    Yatabe, N
    Maida, Y
    Tanaka, M
    Inoue, M
    [J]. NUCLEIC ACIDS RESEARCH, 2001, 29 (14) : 3006 - 3011
  • [33] A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo
    Tsai, EY
    Falvo, JV
    Tsytsykova, AV
    Barczak, AK
    Reimold, AM
    Glimcher, LH
    Fenton, MJ
    Gordon, DC
    Dunn, IF
    Goldfeld, AE
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (16) : 6084 - 6094
  • [34] Myc activates telomerase
    Wang, J
    Xie, LY
    Allan, S
    Beach, D
    Hannon, GJ
    [J]. GENES & DEVELOPMENT, 1998, 12 (12) : 1769 - 1774
  • [35] Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells
    Xu, DW
    Wang, Q
    Gruber, A
    Björkholm, M
    Chen, ZG
    Zaid, A
    Selivanova, G
    Peterson, C
    Wiman, KG
    Pisa, P
    [J]. ONCOGENE, 2000, 19 (45) : 5123 - 5133
  • [36] Interferon or down-regulates telomerase reverse transcriptase and telomerase activity in human malignant and nonmalignant hematopoietic cells
    Xu, DW
    Erickson, S
    Szeps, M
    Gruber, A
    Sangfelt, O
    Einhorn, S
    Pisa, P
    Grandér, D
    [J]. BLOOD, 2000, 96 (13) : 4313 - 4318
  • [37] Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia
    Xu, DW
    Gruber, A
    Peterson, C
    Pisa, P
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (05) : 1367 - 1375
  • [38] Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells
    Xu, DW
    Popov, N
    Hou, M
    Wang, Q
    Björkholm, M
    Gruber, A
    Menkel, AR
    Henriksson, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (07) : 3826 - 3831
  • [39] Rapid induction of histone hyperacetylation and cellular differentiation in human breast tumor cell lines following degradation of histone deacetylase-1
    Zhou, Q
    Melkoumian, ZK
    Lucktong, A
    Moniwa, M
    Davie, JR
    Strobl, JS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (45) : 35256 - 35263